Pfizer Inc

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC PFE

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

35,713,035

Value ($000)

889,255

Weight

0.2%

2013 Q4 - 2025 Q4 (27 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	889,255	0.2%	35,713,035	12/31/2025
2025 Q3	11/14/2025	871,301	0.2%	34,195,484	9/30/2025
2025 Q2	8/14/2025	1,063,595	0.2%	43,877,690	6/30/2025
2025 Q1	5/19/2025	980,422	0.3%	38,690,692	3/31/2025
2024 Q4	2/14/2025	1,045,351	0.2%	39,402,619	12/31/2024
2024 Q3	11/14/2024	1,101,713	0.3%	38,068,879	9/30/2024
2024 Q2	8/14/2024	869,934	0.2%	31,091,292	6/30/2024
2024 Q1	5/15/2024	689,813	0.2%	24,858,131	3/31/2024
2023 Q4	2/14/2024	740,590	0.3%	25,723,857	12/31/2023
2023 Q3	11/13/2023	885,391	0.4%	26,692,514	9/30/2023
2023 Q2	8/11/2023	1,014,913	0.5%	24,875,311	6/30/2023
2023 Q1	5/15/2023	1,014,913	0.5%	24,875,311	3/31/2023
2022 Q4	2/14/2023	1,434,376	0.8%	27,993,292	12/31/2022
2022 Q3	11/14/2022	1,087,240	0.6%	24,845,524	9/30/2022
2022 Q2	8/12/2022	1,362,109	0.7%	25,979,571	6/30/2022
2022 Q1	5/16/2022	1,250,736	0.5%	24,159,476	3/31/2022
2021 Q4	2/14/2022	1,434,884	0.5%	24,299,468	12/31/2021
2021 Q3	11/15/2021	1,020,576	0.4%	23,728,801	9/30/2021
2021 Q2	8/16/2021	911,304	0.4%	23,271,288	6/30/2021
2021 Q1	5/14/2021	791,214	0.3%	21,838,632	3/31/2021
2020 Q4	3/1/2021	766,786	0.4%	20,830,921	12/31/2020
2020 Q3	11/13/2020	754,464	0.4%	20,557,595	9/30/2020
2020 Q2	8/14/2020	745,554	0.5%	22,799,830	6/30/2020
2020 Q1	5/15/2020	755,532	0.5%	23,147,416	3/31/2020
2019 Q4	2/14/2020	812,369	0.5%	20,734,287	12/31/2019
2014 Q1	5/23/2014	776,078	0.8%	24,161,854	3/31/2014
2013 Q4	1/31/2014	685,495	0.8%	22,379,824	12/31/2013